Downregulation of phosphorylated p38 and phosphorylated JNK1/2 via knockdown of amyloid β precursor protein (APP) exerts inhibitory effects towards EMT in NPC by diminishing the mRNA expression levels of MTA-1, MMP-2, and MMP-9 [109]. The gene discussed is MAPK14; the disease is nasopharyngeal carcinoma.